Apyx Medical (APYX) Total Debt Growth (3y) (2013 - 2026)
Apyx Medical (APYX) Total Debt Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | 26.30% |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | 4.07% |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | -0.07% |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | 6.99% |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | 0.11% |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | -0.34% |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 2.61% |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | - |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | -14.39% |
| 10 | Apyx Medical | 205.37 Mn | 174.49 Mn | 7.93 Mn | 58.70% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 58.70% |
| Sep 30, 2023 | 300.73% |
| Jun 30, 2023 | 298.99% |
| Mar 31, 2023 | 297.27% |
| Sep 30, 2020 | -28.25% |
| Jun 30, 2020 | -63.22% |
| Mar 31, 2020 | -28.25% |
| Dec 31, 2019 | -28.25% |
| Sep 30, 2019 | -63.97% |
| Jun 30, 2019 | -64.21% |
| Mar 31, 2019 | -64.44% |
| Dec 31, 2018 | -28.25% |
| Jun 30, 2018 | -7.87% |
| Mar 31, 2018 | -51.64% |
| Dec 31, 2017 | -51.93% |
| Sep 30, 2017 | -52.20% |
| Dec 31, 2016 | 38.07% |
| Mar 31, 2016 | -2.75% |
| Dec 31, 2015 | -51.96% |
| Sep 30, 2015 | -2.16% |